Imatinib Formulations

Aspects of the present application relate to pharmaceutical formulations comprising imatinib or its salts isomers racemates enantiomers hydrates solvates metabolites and polymorphs and mixtures thereof. Further aspects relate to processes for preparing pharmaceutical formulations comprising imatinib or its salts together with at least one pharmaceutically acceptable excipient.